Evaluation of far-field tsunami hazard in French Polynesia based on historical data and numerical simulations

International audienceThe first tsunami hazard map of French Polynesia is presented here on the basis of historical data, and numerical simulations. French Polynesia, because of its central position in the most tsunami prone ocean, the Pacific, is strongly exposed to far-field tsunamis. As no previous study on the area had been conducted, we compiled catalogues of all the historical observations (14 events), and tide gauges records (69 marigrams). The catalogues emphasise the higher hazard associated to the Marquesas archipelago, but also the deficiency of robust data in most other parts of French Polynesia. The recourse to numerical simulations allowed us to complement the existing records, and to test tsunami scenarii over different bathymetry and topography configurations, representative of the diversity of islands in French Polynesia. The tsunami hazard map assigns a high exposure level to the Marquesas and the island of Rurutu. Other islands of the Austral, and the Gambier archipelago have a elevated level of exposure, as well as three islands of Society: Tahiti, Moorea, and Huahine. All other islands of French Polynesia are considered as moderately exposed

Arabidopsis glucosinolates trigger a contrasting transcriptomic response in a generalist and a specialist herbivore.

Phytophagous insects have to deal with toxic defense compounds from their host plants. Although it is known that insects have evolved genes and mechanisms to detoxify plant allochemicals, how specialist and generalist precisely respond to specific secondary metabolites at the molecular level is less understood. Here we studied the larval performance and transcriptome of the generalist moth Heliothis virescens and the specialist butterfly Pieris brassicae feeding on Arabidopsis thaliana genotypes with different glucosinolate (GS) levels. H. virescens larvae gained significantly more weight on the GS-deficient mutant quadGS compared to wild-type (Col-0) plants. On the contrary, P. brassicae was unaffected by the presence of GS and performed equally well on both genotypes. Strikingly, there was a considerable differential gene expression in H. virescens larvae feeding on Col-0 compared to quadGS. In contrast, compared to H. virescens, P. brassicae displayed a much-reduced transcriptional activation when fed on both plant genotypes. Transcripts coding for putative detoxification enzymes were significantly upregulated in H. virescens, along with digestive enzymes and transposable elements. These data provide an unprecedented view on transcriptional changes that are specifically activated by GS and illustrate differential molecular responses that are linked to adaptation to diet in lepidopteran herbivores

Terrestrial–marine connectivity: patterns of terrestrial soil carbon deposition in coastal sediments determined by analysis of glomalin related soil protein

Glomalin, an arbuscular mycorrhizal protein component of soil, can be used as an indicator of terrigenous-derived carbon. We measured glomalin in sediments using the terrestrial end-member as a reference in four coastal settings: (1) intertidal seagrass meadows distributed over a rainfall gradient, (2) sediments inshore and offshore from the mouth of a river, (3) coastal coral reefs at various distances from the shore, and (4) intertidal wetlands with varying levels of groundwater influence. Across the rainfall gradient, glomalin in seagrass meadow sediments increased at sites with high mean annual rainfall during the wet season (r(2) = 0.27; F-1,F-29 = 5.75; p = 0.029). Glomalin decreased in inshore river sediments (terrestrial) to offshore (marine) sediments (r(2) = 0.81; F-1,F-17 = 71.7;

The Measurement Bench for the LHC Spool Corrector Magnets in Industry

The LHC accelerator will be equipped with more than 3500 superconducting spool corrector magnets. CERN has awarded the contract for the series production and testing of these corrector magnets to industry. Magnetic field measurements are done at the factory. Dedicated magnetic measurement benches have been built to test these corrector magnets in the resistive state at room temperature. The benches allow to measure the strength of the main field, normal and skew harmonics, the magnetic axis position and orientation of the main field with respect to the mechanical reference points of the magnet. This paper presents the objectives, a description and the performances obtained with the benches during first measurements at industry

Retrospective suspect and non-target screening combined with similarity measures to prioritize MDMA and amphetamine synthesis markers in wastewater

3,4-Methylenedioxymethamphetamine (MDMA) and amphetamine are commonly used psychoactive stimulants. Illegal manufacture of these substances, mainly located in the Netherlands and Belgium, generates large amounts of chemical waste which is disposed in the environment or released in sewer systems. Retrospective analysis of high-resolution mass spectrometry (HRMS) data was implemented to detect synthesis markers of MDMA and amphetamine production in wastewater samples. Specifically, suspect and non-target screening, combined with a prioritization approach based on similarity measures between detected features and mass loads of MDMA and amphetamine was implemented. Two hundred and thirty-five 24 h-composite wastewater samples collected from a treatment plant in the Netherlands between 2016 and 2018 were analyzed by liquid chromatography coupled to high-resolution mass spectrometry. Samples were initially separated into two groups (i.e., baseline consumption versus dumping) based on daily loads of MDMA and amphetamine. Significance testing and fold-changes were used to find differences between features in the two groups. Then, associations between peak areas of all features and MDMA or amphetamine loads were investigated across the whole time series using various measures (Euclidian distance, Pearson's correlation coefficient, Spearman's rank correlation coefficient, distance correlation and maximum information coefficient). This unsupervised and unbiased approach was used for prioritization of features and allowed the selection of 28 presumed markers of production of MDMA and amphetamine. These markers could potentially be used to detect dumps in sewer systems, help in determining the synthesis route and track down the waste in the environment

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.

BACKGROUND: Synthetic contiguous overlapping peptides (COPs) may represent an alternative to allergen extracts or recombinant allergens for allergen specific immunotherapy. In combination, COPs encompass the entire allergen sequence, providing all potential T cell epitopes, while preventing IgE conformational epitopes of the native allergen. METHODS: Individual COPs were derived from the sequence of Bet v 1, the major allergen of birch pollen, and its known crystal structure, and designed to avoid IgE binding. Three sets of COPs were tested in vitro in competition ELISA and basophil degranulation assays. Their in vivo reactivity was determined by intraperitoneal challenge in rBet v 1 sensitized mice as well as by skin prick tests in volunteers with allergic rhinoconjunctivitis to birch pollen. RESULTS: The combination, named AllerT, of three COPs selected for undetectable IgE binding in competition assays and for the absence of basophil activation in vitro was unable to induce anaphylaxis in sensitized mice in contrast to rBet v 1. In addition no positive reactivity to AllerT was observed in skin prick tests in human volunteers allergic to birch pollen. In contrast, a second set of COPs, AllerT4-T5 displayed some residual IgE binding in competition ELISA and a weak subliminal reactivity to skin prick testing. CONCLUSIONS: The hypoallergenicity of contiguous overlapping peptides was confirmed by low, if any, IgE binding activity in vitro, by the absence of basophil activation and the absence of in vivo induction of allergic reactions in mouse and human. TRIAL REGISTRATION: ClinicalTrials.gov NCT01719133